These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6613196)

  • 1. [Clinical aspects and therapy of schistosomiasis].
    Ziegler K; Möller FW
    Z Gesamte Inn Med; 1983 May; 38(10):59-61. PubMed ID: 6613196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Praziquantel in the treatment of mixed S. haematobium and S. mansoni infections.
    Omer AH
    Arzneimittelforschung; 1981; 31(3a):605-8. PubMed ID: 7195257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan.
    Kardaman MW; Fenwick A; el Igail AB; el Tayeb M; Daffalla AA; Dixon HG
    J Trop Med Hyg; 1985 Apr; 88(2):105-9. PubMed ID: 3897559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel compared to niridazole in schistosomiasis intercalatum therapy.
    Feldmeier H; Zwingenberger K; Steiner A; Dietrich M
    Tropenmed Parasitol; 1981 Mar; 32(1):39-42. PubMed ID: 7233551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
    Mwanakasale V; Vounatsou P; Sukwa TY; Ziba M; Ernest A; Tanner M
    Am J Trop Med Hyg; 2003 Oct; 69(4):420-8. PubMed ID: 14640503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of praziquantel on Schistosoma haematobium, S. japonicum and S. mansoni in primates.
    Webbe G; James C; Nelson GS; Sturrock RF
    Arzneimittelforschung; 1981; 31(3a):542-4. PubMed ID: 7195244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trial of praziquantel in the treatment of urinary schistosomiasis in Senegal].
    Diallo S; Victorius A; Diouf F; Ndir O; Dieng Y; Bah IB
    Arzneimittelforschung; 1981; 31(3a):574-8. PubMed ID: 7195248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium.
    Davis A; Biles JE; Ulrich AM
    Bull World Health Organ; 1979; 57(5):773-9. PubMed ID: 396053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with praziquantel in the treatment of Nigerian patients infected with S. haematobium.
    Oyediran AB; Kofie BA; Bammeke AO; Bamgboye EA
    Arzneimittelforschung; 1981; 31(3a):581-4. PubMed ID: 7016124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of S. intercalatum to praziquantel (author's transl)].
    Deniau M; Eben Moussi E; Same Ekobo A; Ripert C
    Med Trop (Mars); 1981; 41(6):657-9. PubMed ID: 7339424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oltipraz as brief treatment of schistosomiasis (comparison with niridazole) (author's transl)].
    Pieron R; Lesobre B; Mafart Y; Lancastre F
    Med Trop (Mars); 1980; 40(3):301-11. PubMed ID: 6995790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hycanthone therapy in selected patients with S. mansoni and S. haematobium infections in the Sudan.
    Salih SY; Abu Sabaa H; Mustafa D
    J Trop Med Hyg; 1978 Jul; 81(7):126-30. PubMed ID: 702619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths.
    Olds GR; King C; Hewlett J; Olveda R; Wu G; Ouma J; Peters P; McGarvey S; Odhiambo O; Koech D; Liu CY; Aligui G; Gachihi G; Kombe Y; Parraga I; Ramirez B; Whalen C; Horton RJ; Reeve P
    J Infect Dis; 1999 Apr; 179(4):996-1003. PubMed ID: 10068597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic field trial with praziquantel in a rural population in Mali infected with Schistosoma mansoni (author's transl)].
    Ranque P; Konate S; Karemberi B; Kone D
    Arzneimittelforschung; 1981; 31(3a):597-8. PubMed ID: 7195254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on praziquantel against Schistosoma haematobium.
    McMahon JE
    Arzneimittelforschung; 1981; 31(3a):579-80. PubMed ID: 7195249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Historical aspects of the risk factors of Schistosoma intercalatum schistosomiasis].
    Jusot JF; Simarro P; De Muynck A
    Sante; 1996; 6(3):165-72. PubMed ID: 8764451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers.
    Grandière-Pérez L; Ansart S; Paris L; Faussart A; Jaureguiberry S; Grivois JP; Klement E; Bricaire F; Danis M; Caumes E
    Am J Trop Med Hyg; 2006 May; 74(5):814-8. PubMed ID: 16687686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.
    Borrmann S; Szlezák N; Faucher JF; Matsiegui PB; Neubauer R; Binder RK; Lell B; Kremsner PG
    J Infect Dis; 2001 Nov; 184(10):1363-6. PubMed ID: 11679932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole.
    Webster LT; Butterworth AE; Mahmoud AA; Mngola EN; Warren KS
    N Engl J Med; 1975 May; 292(22):1144-7. PubMed ID: 1124104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections.
    N'Goran EK; Utzinger J; Gnaka HN; Yapi A; N'Guessan NA; Kigbafori SD; Lengeler C; Chollet J; Shuhua X; Tanner M
    Am J Trop Med Hyg; 2003 Jan; 68(1):24-32. PubMed ID: 12556143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.